Human Amnion-Derived Mesenchymal Stem Cells Alleviate Lung Injury Induced by White Smoke Inhalation in Rats

类型：

作者：Cui, P., Xin, H., Yao, Y., Xiao, S., Zhu, F., Gong, Z., Tang, Z., Zhan, Q., Qin, W., Lai, Y., Li, X., Tong, Y. & Xia, Z.
期刊：Stem cell research & therapy 9, 101 (2018)
阅读原文

BACKGROUND: White smoke inhalation (WSI) is an uncommon but potentially deadly cause of acute lung injury and acute respiratory distress syndrome for which no effective pharmaceutical treatment has been developed. This study aimed to determine the protective effects of human amnion-derived mesenchymal stem cells (hAMSCs) against WSI-induced lung injury in rats. METHODS: hAMSCs were injected into rats via the tail vein 4?h after WSI. At 1, 3, 7, 14, and 28?days after cell injection, hAMSCs labeled with PKH26 in lung, heart, liver, and kidney tissues were observed by fluorescence microscopy. The lung injury score was determined by hematoxylin and eosin staining. Lung fibrosis was assessed by Masson's trichrome staining. The computed tomography (CT) score was assessed by CT scanning. The wet/dry weight ratio was calculated. The levels of interleukin (IL)-1β, IL-6, and IL-10 were determined by enzyme-linked immunosorbent assays. The expression of surfactant protein (SP)-A, SP-C, and SP-D was measured by Western blotting. RESULTS: The injected hAMSCs were primarily distributed in the lung tissues in WSI-induced rats. Compared with the model and phosphate-buffered saline (PBS) group, hAMSC treatment led to reduced lung injury, lung fibrosis, CT score, and inflammation levels in WSI-induced mice. hAMSC treatment also resulted in increased cell retention in the lung, partial pressure of oxygen (PaO(2)), and PaO(2)/fraction of inspired oxygen (FiO(2)) levels, and pulmonary SP-A, SP-C, and SP-D expression compared with that in the model and PBS group. CONCLUSIONS: hAMSCs are a potential cell-based therapy for WSI-induced lung injury.